The Company is a Korea-based manufacturer engaged in the provision of pharmaceutical products. The Company produces prescription drugs such as circulatory improvement agents, antiplatelet agents, osteoporosis drugs, antiulcerants, bone metabolism ameliorants, gout preparative drugs, antidepressants, anti-diabetic agents, antitubercular agents, antihypertensive agents, angina pectoris drugs, antibiotics, hemorrhoidal and varicose preparations and topical corticosteroids, as well as non-prescription drugs including vitamins and digestive agents. It also provides healthcare supplements and quasi drugs. In addition, the Company is involved in the development of medicines for geriatric diseases such as osteoporosis, dementia, stroke and others. The Company was established in February 1941. The Company shares are listed on the Korea Stock Exchange on November 18, 1975.
Headquarters
983 Wangam-Dong, Jecheon-Si
Jecheon; Chungcheongbuk;
Postal Code: 390-250
Contact Details: Purchase the Yuyu Pharma Inc. report to view the information.
Website: http://www.yuyu.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service